Barcelona, Spain

Josep M Suñé Negre

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Fundacio De Recerca Clinic Barcelona-Institut D'investigacions Biomediques August Pi I Sunyer, Hospital Clinic De Barcelona, Universität De Barcelona. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josep M Suñé Negre. Retrieved from https://idiyas.com/inventor/josep-m-suñé-negre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Josep M Suñé Negre: Innovator in Pharmaceutical Composition

Introduction

Josep M Suñé Negre is an inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of live fecal microbiota. Although he currently holds no granted patents, his work is noteworthy for its potential therapeutic applications.

Latest Patent Applications

Josep M Suñé Negre has filed several patent applications, including one for a "Long-Term Stable Live Fecal Microbiota Composition." This invention provides a solid oral pharmaceutical composition that includes a pharmaceutically effective amount of living microorganisms and one or more pharmaceutically acceptable water-absorbing excipients. The composition is designed to have a water content ranging from 0.5 to 30% of the total weight, as determined by the European Pharmacopoeia. The invention also outlines processes for preparation and therapeutic use, emphasizing the stability of the live-cell based composition under mild conditions.

Conclusion

Josep M Suñé Negre's innovative work in pharmaceutical compositions highlights the importance of research in developing effective therapies. His contributions, although not yet patented, pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…